Alex Denoon

Alex is passionate about the life sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience, including as GC of a biopharmaceutical company, and brings 25 years’ experience advising clients in the sector.

In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices (including in vitro diagnostics).

Alex advises clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products.

The life sciences sector sees some of the most exciting and influential deployments of Artificial Intelligence and machine learning. The increasing use of AI in the sector poses a number of regulatory challenges (including entirely new regulations) and he specialises in helping clients navigate these.

Alex has been involved in the development of a number of regulatory frameworks and guidelines.

LLB, University of New South Wales

BSc Human Genetics, University of New South Wales

Qualified 1995

Partner 2009

Biotech Review of the Year